Literature DB >> 21459896

Failure of conventional treatment with pyrimethamine and sulfadiazine for secondary prophylaxis of cerebral toxoplasmosis in a patient with AIDS.

Benoît Faucher, Jacques Moreau, Olivia Zaegel, Jacqueline Franck, Renaud Piarroux.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21459896     DOI： 10.1093/jac/dkr147

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  5 in total

1.  Significant reduction of brain cysts caused by Toxoplasma gondii after treatment with spiramycin coadministered with metronidazole in a mouse model of chronic toxoplasmosis.

Authors:  Wai Kit Chew; Ignacio Segarra; Stephen Ambu; Joon Wah Mak
Journal:  Antimicrob Agents Chemother       Date:  2012-01-23       Impact factor: 5.191

2.  Anti-Toxoplasma activity and chemical compositions of aquatic extract of Mentha pulegium L. and Rubus idaeus L.: An in vitro study.

Authors:  Hanieh Mohammad Rahimi; Mojdeh Khosravi; Zahra Hesari; Meysam Sharifdini; Hamed Mirjalali; Mohammad Reza Zali
Journal:  Food Sci Nutr       Date:  2020-06-08       Impact factor: 2.863

3.  Curcumin nanoemulsion as a novel chemical for the treatment of acute and chronic toxoplasmosis in mice.

Authors:  Sanaz Jafarpour Azami; Aref Teimouri; Hossein Keshavarz; Amir Amani; Fariba Esmaeili; Hamid Hasanpour; Samira Elikaee; Hamid Salehiniya; Saeedeh Shojaee
Journal:  Int J Nanomedicine       Date:  2018-11-09

4.  Forward genetic screening identifies a small molecule that blocks Toxoplasma gondii growth by inhibiting both host- and parasite-encoded kinases.

Authors:  Kevin M Brown; Elena Suvorova; Andrew Farrell; Aaron McLain; Ashley Dittmar; Graham B Wiley; Gabor Marth; Patrick M Gaffney; Marc Jan Gubbels; Michael White; Ira J Blader
Journal:  PLoS Pathog       Date:  2014-06-12       Impact factor: 6.823

5.  In vitro Evaluation of Mannosylated Paromomycin-Loaded Solid Lipid Nanoparticles on Acute Toxoplasmosis.

Authors:  Mojdeh Khosravi; Hanieh Mohammad Rahimi; Delaram Doroud; Elnaz Sadat Mirsamadi; Hamed Mirjalali; Mohammad Reza Zali
Journal:  Front Cell Infect Microbiol       Date:  2020-02-13       Impact factor: 5.293
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.